Skip to content

Clinical trials

Observational Breast Neoplasms trials in Italy

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Breast Neoplasms Phase: Observational Country / region: Italy Clear all

168 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20041
20051
20072
20082
20091
20103
20114
20125
20145
20155
20165
20173
201810
20198
202010
20219
202222
202329
202419
202518
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting57
Completed50
Unknown status41
Active, not recruiting11
Enrolling by invitation4
Not yet recruiting3
Terminated2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
European Institute of Oncology22
Fondazione Policlinico Universitario Agostino Gemelli IRCCS14
Istituti Clinici Scientifici Maugeri SpA11
Regina Elena Cancer Institute10
Centro di Riferimento Oncologico - Aviano9
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano6
AstraZeneca5
Consorzio Oncotech5
IRCCS Azienda Ospedaliero-Universitaria di Bologna5
Graziella di Grezia3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Breast Neoplasms168
Neoplasms10
Lung Neoplasms9
Ovarian Neoplasms8
Melanoma6
Head and Neck Neoplasms5
Prostatic Neoplasms5
Urinary Bladder Neoplasms5
Breast Diseases4
Colorectal Neoplasms4

Trials

Showing 1 to 25 of 168. Each trial links to its page on Pharma Observatory.

68 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.